2025
SJR Q2
JCR Q2 · 2,8
266 matched articles
SCIE
Journal detail
Clinical and Experimental Dermatology
- Publisher
- Oxford University Press
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0307693813652230
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,657
- Quartile Q2
- H-Index 97
- Cites/doc 1,3
- Docs (3y) 1.441
- Cites (3y) 2.042
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,8
- 5Y JIF 3
- JCI 0,75
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q2
Areas
- Medicine
WoS categories
- Dermatology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,657 | 2,8 | 3 | 0,75 | Q2 | 97 |
| 2024 | Q2 | Q2 | 0,692 | 2,9 | 3,2 | 0,84 | Q2 | 92 |
| 2023 | Q2 | Q1 | 0,705 | 3,7 | 3,4 | 0,8 | Q2 | 92 |
| 2022 | Q2 | Q1 | 0,577 | 4,1 | 3,4 | 0,79 | Q2 | 92 |
| 2021 | Q2 | Q1 | 0,487 | 4,5 | 3,2 | 0,79 | Q2 | 92 |
| 2020 | Q2 | Q2 | 0,587 | 3,5 | 2,7 | 0,75 | Q2 | 92 |
| 2019 | Q2 | Q3 | 0,525 | 2 | 1,7 | 0,64 | Q2 | 92 |
| 2018 | — | Q3 | — | 1,8 | 1,6 | 0,66 | Q2 | — |
| 2017 | Q2 | Q3 | 0,597 | 1,5 | 1,5 | 0,64 | Q2 | 92 |
| 2016 | Q2 | Q3 | 0,558 | 1,6 | 1,5 | — | — | 92 |
| 2015 | Q2 | Q3 | 0,565 | 1,3 | 1,3 | — | — | 92 |
| 2014 | Q2 | Q3 | 0,6 | 1,1 | 1,3 | — | — | 92 |
| 2013 | Q2 | Q3 | 0,678 | 1,2 | 1,3 | — | — | 92 |
| 2012 | Q2 | Q3 | 0,648 | 1,3 | 1,4 | — | — | 92 |
| 2011 | Q2 | Q3 | 0,603 | 1,2 | 1,5 | — | — | 92 |
| 2010 | Q2 | Q3 | 0,558 | 1,3 | 1,5 | — | — | 92 |
| 2009 | — | Q3 | — | 1,6 | 1,7 | — | — | — |
| 2008 | — | Q2 | — | 1,8 | 1,7 | — | — | — |
| 2007 | — | Q2 | — | 1,5 | 1,6 | — | — | — |
| 2006 | — | Q3 | — | 1,3 | — | — | — | — |
| 2005 | — | Q2 | — | 1,4 | — | — | — | — |
| 2004 | — | Q2 | — | 1,1 | — | — | — | — |
| 2003 | — | Q2 | — | 1,2 | — | — | — | — |
| 2002 | — | Q2 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
| 2000 | — | Q4 | — | 0,6 | — | — | — | — |
| 1999 | — | Q4 | — | 0,5 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 0,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q2 | Q2 | 36/99 |
| 2024 | DERMATOLOGY | SCIE | Q2 | Q2 | 30/96 |
| 2023 | DERMATOLOGY | SCIE | Q1 | Q2 | 18/94 |
| 2022 | DERMATOLOGY | SCIE | Q1 | Q2 | 14/70 |
| 2021 | DERMATOLOGY | SCIE | Q1 | Q2 | 16/69 |
| 2020 | DERMATOLOGY | SCIE | Q2 | Q2 | 25/69 |
| 2019 | DERMATOLOGY | SCIE | Q3 | Q2 | 38/68 |
| 2018 | DERMATOLOGY | SCIE | Q3 | Q2 | 38/66 |
| 2017 | DERMATOLOGY | SCIE | Q3 | Q2 | 44/64 |
| 2016 | DERMATOLOGY | SCIE | Q3 | — | 36/63 |
| 2015 | DERMATOLOGY | SCIE | Q3 | — | 43/61 |
| 2014 | DERMATOLOGY | SCIE | Q3 | — | 45/63 |
| 2013 | DERMATOLOGY | SCIE | Q3 | — | 41/61 |
| 2012 | DERMATOLOGY | SCIE | Q3 | — | 35/59 |
| 2011 | DERMATOLOGY | SCIE | Q3 | — | 37/58 |
| 2010 | DERMATOLOGY | SCIE | Q3 | — | 35/55 |
| 2009 | DERMATOLOGY | SCIE | Q3 | — | 26/48 |
| 2008 | DERMATOLOGY | SCIE | Q2 | — | 20/43 |
| 2007 | DERMATOLOGY | SCIE | Q2 | — | 18/41 |
| 2006 | DERMATOLOGY | SCIE | Q3 | — | 24/39 |
| 2005 | DERMATOLOGY | SCIE | Q2 | — | 17/39 |
| 2004 | DERMATOLOGY | SCIE | Q2 | — | 19/38 |
| 2003 | DERMATOLOGY | SCIE | Q2 | — | 17/38 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q2 | — | 18/40 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 28/38 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 29/36 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 28/36 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 25/35 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 23/32 |